78 related articles for article (PubMed ID: 4972891)
1. [Effect of blood loss during mastectomy on endurance of radiation and chemotherapy].
Shnittser IuM
Vopr Onkol; 1968; 14(10):21-5. PubMed ID: 4972891
[No Abstract] [Full Text] [Related]
2. Ultracision reduces acute blood loss but not seroma formation after mastectomy and axillary dissection: a pilot study.
Adwani A; Ebbs SR
Int J Clin Pract; 2006 May; 60(5):562-4. PubMed ID: 16700855
[TBL] [Abstract][Full Text] [Related]
3. Ovarian ablation for breast cancer.
Br Med J; 1971 Apr; 2(5754):123. PubMed ID: 4996470
[No Abstract] [Full Text] [Related]
4. Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes.
Wright JL; Cordeiro PG; Ben-Porat L; Van Zee KJ; Hudis C; Beal K; McCormick B
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):43-50. PubMed ID: 17855006
[TBL] [Abstract][Full Text] [Related]
5. Letter: New hope in breast cancer treatment.
Ackland TH
Med J Aust; 1975 Jul; 2(4):151. PubMed ID: 808694
[No Abstract] [Full Text] [Related]
6. Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma.
Ravdin RG; Lewison EF; Slack NH; Dao TL; Gardner B; State D; Fisher B
Surg Gynecol Obstet; 1970 Dec; 131(6):1055-64. PubMed ID: 4991334
[No Abstract] [Full Text] [Related]
7. [Risk factors for lymphedema of the arm after mastectomy for breast cancer].
Kasse AA; Diop M; Dieng M; Deme A; Ndaw D; Fall MG; Diop PS; Betel E; Dembele B; Drabo B; Timbely G; Toure P
Dakar Med; 1999; 44(1):32-5. PubMed ID: 10797983
[TBL] [Abstract][Full Text] [Related]
8. Cancer of the breast. Endocrine ablation, hormone therapy and chemotherapy.
Donegan WL
Major Probl Clin Surg; 1967; 5():201-44. PubMed ID: 5005673
[No Abstract] [Full Text] [Related]
9. Initial treatment of carcinoma of the breast, stages I and II.
Getzen LC
Am J Surg; 1967 Mar; 113(3):358-62. PubMed ID: 4959902
[No Abstract] [Full Text] [Related]
10. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
[TBL] [Abstract][Full Text] [Related]
11. [Long-term results of treatment of 3,359 patients with breast cancer].
Semiglazov VF; Rzhankov SV; Migmanova NSh; Kremen' BV; Barash NIu
Vopr Onkol; 1983; 29(12):25-30. PubMed ID: 6666094
[TBL] [Abstract][Full Text] [Related]
12. [On chemotherapy of patients with cancer of the mammary glands].
Oleinik VA
Vopr Onkol; 1969; 15(1):86-7. PubMed ID: 4977503
[No Abstract] [Full Text] [Related]
13. [Treatment of breast cancer with ipsilateral supraclavicular node metastases].
Ning L; Yu J; Lin C
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):139-41. PubMed ID: 7656807
[TBL] [Abstract][Full Text] [Related]
14. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
[TBL] [Abstract][Full Text] [Related]
15. Complications and toxic manifestations of surgical adjuvant chemotherapy for breast cancer.
Cohn I
Surg Gynecol Obstet; 1968 Dec; 127(6):1201-9. PubMed ID: 4973320
[No Abstract] [Full Text] [Related]
16. [Preventive value of radiation and drug therapy in breast cancer].
Karev NI; Garin AM; Blokhina NG; Alferova MS; Bazhenova AP
Khirurgiia (Mosk); 1971 Aug; 47(8):64-8. PubMed ID: 5001927
[No Abstract] [Full Text] [Related]
17. [Combined chemotherapy and radiation therapy in breast cancer: a retrospective study of 406 patients (author's transl)].
Jacquillat C; Auclerc G; Auclerc MF; Weil M; Bassot V; Debonnière C
Bull Cancer; 1981; 68(2):166-70. PubMed ID: 7016223
[TBL] [Abstract][Full Text] [Related]
18. Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer.
Okumura A; Tokuda Y; Ohta M; Suzuki Y; Saito Y; Kuge S; Kubota M; Makuuchi H; Tajima T; Nakamura Y; Hotta T
Tokai J Exp Clin Med; 1999 Dec; 24(4-6):141-6. PubMed ID: 10819494
[TBL] [Abstract][Full Text] [Related]
19. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
20. [Effect of cytostatics on tumor cells].
Sergel' OS; Kopeĭko IP; Kachkov AP
Sov Med; 1980; (12):53-6. PubMed ID: 6784250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
